Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofol

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Anesthesia

Conditions

Anesthesia

Trial Timeline

Nov 1, 2010 โ†’ Mar 1, 2011

About Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofol

Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofol is a approved stage product being developed by Eisai for Anesthesia. The current trial status is completed. This product is registered under clinical trial identifier NCT01260142. Target conditions include Anesthesia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01260142ApprovedCompleted